COUNTERREGULATORY HORMONE RESPONSES AND SYMPTOMS DURING HYPOGLYCEMIA-INDUCED BY PORCINE, HUMAN REGULAR INSULIN, AND LYS(B28), PRO(B29) HUMAN INSULIN ANALOG (INSULIN LISPRO) IN HEALTHY MALE-VOLUNTEERS
Majm. Jacobs et al., COUNTERREGULATORY HORMONE RESPONSES AND SYMPTOMS DURING HYPOGLYCEMIA-INDUCED BY PORCINE, HUMAN REGULAR INSULIN, AND LYS(B28), PRO(B29) HUMAN INSULIN ANALOG (INSULIN LISPRO) IN HEALTHY MALE-VOLUNTEERS, Diabetic medicine, 14(3), 1997, pp. 248-257
Lys(B28)Pro(B29) human insulin analogue (Lispro) is a newly developed
monomeric insulin analogue with a vapid onset and short duration of ac
tion. The aim of the study was to compare the thresholds for the count
erregulatory responses during a stepwise euglycaemic/hypoglycaemic cla
mp for insulin lispro (LP), human (H), and porcine (P) insulin in a ra
ndomized order in 12 healthy male volunteers (age 22.4 +/- 1.7 years,
BMI 21.9 +/- 1.7 kg m(-2)). A euglycaemic period of 2 h was followed b
y three hypoglycaemic levels of 60 min each: from 150-210 min at 3.5 m
mol l(-1), 240-300 min at 3.0 mmol l(-1), and 330-390 min at 2.5 mmol
l(-1). Plasma insulin levels during the 50 mU kg(-1) h(-1) infusions a
cid blood glucose levels were not significantly different. The glucose
requirements (mean +/- SD) during the last part of the euglycaemic pe
riod (90-120 min) tended to be higher during LP compared to those duri
ng H and P; 2239 +/- 702 and 1929 +/- 769, 1957 +/- 725 mg kg(-1), P =
0.067, respectively. The thresholds (blood glucose level at which a s
ustained elevation of the counterregulatory hormones as compared to th
e mean at normoglycaemia level 4.0 mmol l(-1), occurs) for the various
hormones were very similar during LP, H, and P insulin infusions and
occurred at 253.8 +/- 56.7, 256.3 +/- 55.3 and 257.5 +/- 70.0 min for
adrenaline; 241.4 +/- 80.3, 260.5 +/- 82.5 and 225.0 +/- 75.9 min for
noradrenaline; 307.5 +/- 65.5, 304.1 +/- 74.1 and 322.5 +/- 40.4 min f
or cortisol; 263.8 +/- 50.3, 255.0 +/- 63.6 and 249.6 +/- 50.9 min for
growth hormone; 236.3 +/- 78.2, 200.0 +/- 73.1 and 226.3 +/- 65.5 for
pancreatic polypeptide, The autonomic and neuroglycopenic symptoms we
re elicited at 240 and 300 min, respectively. In conclusion, our data
indicate a tendency to a higher biological activity of approximately 1
0 % for Lispro insulin. During a stepwise euglycaemic/hypoglycaemic cl
amp, the counterregulatory hormone responses to insulin lispro, human
insulin, and porcine insulin were similar.